Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...

The COVID pandemic disrupted routine testing practices for flu, RSV, and other common infections. Now expensive "large-panel" tests appear over-used. Pediatric hospitals across the US have been ...

Spending on respiratory pathogen testing at U.S. children’s hospitals has surged more than fourfold since 2016, as testing rates climbed from 13.6% of emergency department visits to 62.2% in 2022, ...

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

Last year, at least one million people in the U.S. were hospitalized for respiratory virus illnesses like the flu or COVID-19, according to the Centers for Disease Control and Prevention. Many of ...

The growing demand for respiratory disease testing is largely driven by the increasing global prevalence of respiratory disorders. Furthermore, the rising risk factors linked to these disorders, along ...

WHEN OSHA's revised Respiratory Protection Standard for General Industry, 29 CFR 1910.134, became effective on April 8, 1998, it provided employers with an all-inclusive reference source for fit ...

If proven to be accurate, the point-of-care test could provide the NHS with a highly scalable, low-cost diagnostic tool. It ...

The Occupational Safety and Health Administration (OSHA) on Sept. 25 issued a final rule approving two additional quantitative fit testing protocols for inclusion in its Respiratory Protection ...

The respiratory pathogen testing kits market may rise from USD 4,304.6 Million in 2025 to USD 7,352.9 Million by 2035, with a CAGR of 5.5% over the forecast period. The global respiratory pathogen ...